At 11:40M, the 30-share Sensex was down 6 points at 27,925 and the 50-share Nifty was down 15 points at 8,480.
In the broader market, the BSE Mid-cap was trading flat while Small-cap index was trading with marginal losses.
Also Read
The US oil price tumbled to a fresh six-year low on Wednesday on the latest sign of a glut in crude supplies.
RUPEE
The Indian rupee was trading flat with positive bias at 65.20 against the US dollar after on fresh selling of dollars by banks and exporters.
SECTORS & STOCKS
Defensive sectors such as IT & Healthcare were up 2% while IT and Metal were the top losers down over 1.5% each.
Pharma major Lupin was the top Sensex gainer up 6% after it said it has received approval from USFDA for Fenofibrate tablets in dosages of 160 mg and 54 mg. Fenofibrate is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease.
Sun Pharmaceutical was up 3.5% after it announced that the USFDA has approved its supplemental new drug application for Ximino extended release capsules dispensed for inflammatory lesions of non-nodular moderate to severe acne. Among others, Dr Reddy's Labs and Cipla were up 0.8-1.6% each.
Oil shares trimmed early gains and were trading with losses amid falling global crude oil prices. Reliance Industries was down over 1%. The company received approval to set up payments bank. ONGC was down 2.1%.
Bharti Airtel was up 1% while Aditya Birla Nuvo was up 0.5% were among thise which received 'in principle' approval for setting up payments banks.
Metal stocks are losing sheen on the back of Chinese economic slowdown. Tata Steel, Hindalco and Vedanta have dropped between 0.5-1.5%.
IT shares which had rallied in the previous sessions on the back of a weakening rupee witnessed profit taking. Infosys, TCS and Wipro were down 0.3-3% each.
Other Sensex losers include, Axis Bank, Tata Motors and L&T among others.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)